宋婷

个人信息Personal Information

副教授

硕士生导师

性别:女

毕业院校:大连理工大学

学位:博士

所在单位:医学部

学科:有机化学. 细胞生物学

办公地点:大连理工大学西部新校区化学综合楼C508

联系方式:Email: songting@dlut.edu.cn Tel: 18098885828

电子邮箱:songting@dlut.edu.cn

扫描关注

论文成果

当前位置: 中文主页 >> 科学研究 >> 论文成果

Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach

点击次数:

论文类型:期刊论文

发表时间:2013-01-01

发表刊物:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

收录刊物:SCIE、PubMed、Scopus

卷号:59

页面范围:141-149

ISSN号:0223-5234

关键字:Mcl-1; Small molecule inhibitor; Fragment-based approach; Anticancer

摘要:Based on a known nanomolar Bcl-2 homology domain 3 (BH3) mimetic 3-thiomorpholin-8-oxo-8H-acenaphtho[1,2-b] pyrrole-9-carbonitrile (SI, MW: 331), we applied a fragment-based approach to obtain BH3 mimetics with improved affinity and improved solubility in a water ethanol (9:1) cosolvent. After the deconstruction of 1 (S1), we obtained fragment cyanoacetamide (4), which was determined to be a ligand efficiency (LE) hot part. After a rational optimization through fragment evolution beginning with fragment 4, a smaller Mcl-1 inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g, MW: 288) with a 6-fold increase in affinity compared to I was obtained, as predicted by our optimization curve and identified by Mcl-1 protein nuclear magnetic resonance (NMR). (C) 2012 Elsevier Masson SAS. All rights reserved.